GW Pharmaceuticals PLC Holding(s) in Company (7066H)
18 March 2015 - 4:15AM
UK Regulatory
TIDMGWP TIDMPRU
RNS Number : 7066H
GW Pharmaceuticals PLC
17 March 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or the underlying GW Pharmaceuticals Plc
issuer
of existing shares to which voting rights
are
attached:
----------------------------------------------- ------------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
-------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
---------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
---------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
---------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights
---------------------------------------------------------------------------- -------
Other (please specify):
------------------------------------------------------------------------ -------
3. Full name of person(s) subject Prudential plc group of companies
to the
notification obligation:
----------------------------------------- ------------------------------------------
4. Full name of shareholder(s) See attached schedule
(if different from 3.):
----------------------------------------- ------------------------------------------
5. Date of the transaction and date 16 March 2015
on
which the threshold is crossed
or
reached:
----------------------------------------- ------------------------------------------
6. Date on which issuer notified: 17 March 2015
----------------------------------------- ------------------------------------------
7. Threshold(s) that is/are crossed
or
reached: 12% - 11%
----------------------------------------- ------------------------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
------------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------------- -----------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights
Shares Voting
Rights
------------- --------------- --------------------- ------------- ------------------------- -----------------------------
Direct Direct Indirect Direct Indirect
------------- --- ---- ---- ------ ----- --- ------------- -------------- --------- --------------- ------------
GB0030544687 21,450,529 21,450,529 21,450,529 21,450,529 0 9.04% 0
------------- --------------- --------------------- ------------- -------------- --------- --------------- ------------
US36197T1034 603,008 7,236,096 557,591 6,691,092 0 2.82% 0
------------- --------------- --------------------- ------------- -------------- --------- --------------- ------------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
be
acquired if the
instrument is
exercised/ converted.
------------------------ --------------- -------------------------------- ----------------------------- ------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
------------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights
instrument price date Conversion rights instrument
period refers to
------------------ ------------- ------------- ------------------ ------------------------------ ------------------------
Nominal Delta
------------------ ------------- ------------- ------------------ ------------------------------ ------------- ---------
Total (A+B+C)
------------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------------------------ ----------------------------------------------------------
28,141,621 11.86%
------------------------------------------------------------------ ----------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable:
----------------------------------------------------------------------------------
Prudential plc (parent Company)
M&G Group Limited (wholly owned subsidiary of Prudential plc)
M&G Limited (wholly owned subsidiary of M&G Group Limited)
M&G Investment Management Limited (wholly owned subsidiary of M&G Limited)
M&G Securities Limited (wholly owned subsidiary of M&G Limited)
Proxy Voting:
----------------------------------------------------------------------------------
10. Name of the proxy holder: N/A
----------------------------------------------------- ---------------------------
11. Number of voting rights proxy holder will N/A
cease
to hold:
----------------------------------------------------- ---------------------------
12. Date on which proxy holder will cease to N/A
hold
voting rights:
----------------------------------------------------- ---------------------------
13. Additional information:
----------------------------------------- ---------------------------------------
14. Contact name: Owen Smith / James Todd
M&G Investment Management Limited
----------------------------------------- ---------------------------------------
15. Contact telephone number: 020 7004 4517 / 020 7548 2293
----------------------------------------- ---------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAXDXFFDSEFF
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles